FLEX 500 500 MG
EICOSAPENTAENOIC ACID (FISH OIL) : 500 MG · DIN 02242996 · OCEAN NUTRITION CANADA LTD.
Health Canada status: CANCELLED POST MARKET
What is FLEX 500?
FLEX 500 500 MG contains EICOSAPENTAENOIC ACID (FISH OIL) : 500 MG. It is listed in the Health Canada Drug Product Database under DIN 02242996, held by OCEAN NUTRITION CANADA LTD., supplied as CAPSULE for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 20-Jul-2009. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02242996 |
|---|---|
| Brand name | FLEX 500 |
| Generic / active ingredient | EICOSAPENTAENOIC ACID (FISH OIL) : 500 MG |
| Manufacturer | OCEAN NUTRITION CANADA LTD. |
| Strength | 500 MG |
| Dosage form | CAPSULE |
| Route of administration | ORAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | C10AX06 OMEGA-3-TRIGLYCERIDES INCL. OTHER ESTERS AND ACIDS |
| AHFS class | 88:30.00* ; See footnote |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 20-Jul-2009 |
| Original market date | 2001-03-28 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code C10AX06 OMEGA-3-TRIGLYCERIDES INCL. OTHER ESTERS AND ACIDS. 1 of 4 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| VASCEPA | 1 G | CAPSULE | HLS THERAPEUTICS INC | MARKETED | DIN 02495244 |
| HERBALIFELINE | 78 MG | CAPSULE | HERBALIFE INTERNATIONAL OF LUXEMBOURG S À R L | CANCELLED POST MARKET | DIN 02248423 |
| OMEGA-3 | 200 MG | CAPSULE | WN PHARMACEUTICALS LTD. | CANCELLED POST MARKET | DIN 02248743 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.